The results of formulation analysis for the high dose group were below the lower limit of the range defined at XXXXXXXX on the first and last days of dosing ( for the samples before and after dosing on Day 1 and for the sample before dosing on Day 28 ) .
The results of formulation analysis for the high dose group were below the lower limit of the range defined at XXXXXXXX on the first and last days of dosing ( for the samples before and after dosing on Day 1 and for the sample before dosing on Day 28 ) .
O O O O O O O B-GROUP I-GROUP I-GROUP O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O